相关实验视频

Updated: Sep 16, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

在团队合作,目标,技术和严格控制 (4T) 研究中,在36个月内持续改善HbA1c

Priya Prahalad^1,2, Victoria Y Ding³, Dessi P Zaharieva¹

¹Department of Pediatrics, Division of Pediatric Endocrinology, Stanford University, Stanford, CA.

The Journal of clinical endocrinology and metabolism

|July 10, 2025

概括

患有1型糖尿病 (T1D) 的青少年在3年内持续改善了血红蛋白A1c (HbA1c) 水平,并进行了密集的早期治疗. 这项研究强调了在诊断后的第一年集中T1D护理的长期益处.

科学领域:

儿科内分泌学儿科内分泌学
代谢障碍代谢障碍代谢障碍
糖尿病管理糖尿病管理

背景情况:

患有1型糖尿病 (T1D) 的年轻人往往难以达到和维持血红蛋白A1c (HbA1c) 的目标水平.
试点4T研究之前表明,与历史对照相比,在1年内患有T1D的年轻人中HbA1c改善0.5%.

研究的目的:

在试点4T研究队列中,在三年内评估持续的血糖结果.
评估早期糖尿病密集管理对HbA1c和持续血糖监测 (CGM) 指标的长期影响.

主要方法:

试点4T扩展队列的未来后续行动,包括T1D的年轻人.
采用连续血糖监测 (CGM) 和远程患者监测 (RPM) 与强化教育.
在T1D诊断后的前三年收集HbA1c和CGM数据.

主要成果:

78.5%的参与者参加了研究延期,持续了三年.
与历史队列相比,试点4T队列在3年后显示了明显较低的调整HbA1c (1.2%较低).
在3年后,Pilot 4T参与者的68%和37%分别达到HbA1c目标<7.5%和<7%,而历史组的37%和20%相比.

结论:

在青少年T1D诊断的第一年进行密集管理,导致HbA1c在三年内持续改善.
在儿童1型糖尿病护理中的早期,专注的干预可以对长期的血糖控制产生积极影响.

关键词:

糖尿病技术技术医疗保健医疗保健提供医疗保健提供儿科糖尿病儿科糖尿病一类糖尿病一类糖尿病

更多相关视频

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

相关概念视频

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...